About AVO
AVO is the oversea subsidiary of Nanjing Synthgene Medtech Group. Based on the strong R&D capabilities and manufacturing capacity of its holding company, AVO is specialized in the development and production of in-vitro diagnostic materials and POCT reagents, well represented by its established technological platforms including protein expression and purification platforms, hybridoma monoclonal antibody screening platforms and antibody engineering design platforms etc. that are the essence of the development of diagnostic antibodies.